Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Effects of anakinra on the LV end-systolic volume index in patients with myocardial infarction

Next Previous
Trial Profile

Effects of anakinra on the LV end-systolic volume index in patients with myocardial infarction

Status: Completed
Phase of Trial: Phase II

Latest Information Update: 26 Dec 2023

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Anakinra (Primary)
  • Indications Heart failure; Myocardial infarction
  • Focus Therapeutic Use
  • Acronyms VCU-ART2

    • Most Recent Events

    • 13 Nov 2023 Results assessing sex-based differences in the systemic inflammation (CRP levels) and composite end-point of new-onset HF or death in patients with STEMI from three different Virginia Commonwealth University Anakinra Response Trial (VCU-ART) randomized clinical trials VCU-ART, VCU-ART-2 & VCU-ART-3 presented at the American Heart Association Scientific Sessions 2023.
    • 01 Aug 2023 Results assessing Comparison of Safety and Biological Efficacy of Anakinra (Kineret) Dispensed in Polycarbonate Plastic versus Borosilicate Glass Syringes of VCUART2 and VCUART3 Clinical Trials published in the Journal of Pharmacology and Experimental Therapeutics
    • 18 Nov 2019 Results (n=63) assessing data from anakinra groups for 14 days after STEMI were presented at the American Heart Association Scientific Sessions 2019
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Legal
Back to top